Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Other Operating Expenses (2019 - 2025)

Bioadaptives' Other Operating Expenses history spans 7 years, with the latest figure at $18569.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 77.23% year-over-year to $18569.0; the TTM value through Sep 2025 reached $285442.0, up 32.54%, while the annual FY2024 figure was $270814.0, 95.87% up from the prior year.
  • Other Operating Expenses for Q3 2025 was $18569.0 at Bioadaptives, down from $82390.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $207758.0 in Q1 2021 and bottomed at $8919.0 in Q1 2023.
  • The 5-year median for Other Operating Expenses is $63157.0 (2023), against an average of $61506.6.
  • The largest annual shift saw Other Operating Expenses soared 662.84% in 2021 before it tumbled 87.44% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $63384.0 in 2021, then tumbled by 82.79% to $10911.0 in 2022, then skyrocketed by 113.21% to $23263.0 in 2023, then skyrocketed by 238.38% to $78718.0 in 2024, then tumbled by 76.41% to $18569.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Other Operating Expenses are $18569.0 (Q3 2025), $82390.0 (Q2 2025), and $105765.0 (Q1 2025).